Administration of CI-1033, an Irreversible Pan-erbB Tyrosine Kinase Inhibitor, Is Feasible on a 7-Day On, 7-Day Off Schedule
暂无分享,去创建一个
A. Tolcher | P. LoRusso | A. Patnaik | E. Rowinsky | P. Lenehan | L. Hammond | J. D. de Bono | S. Olson | E. Calvo | I. Eiseman | H. McCreery | Heather McCreery